Clinical Trials Logo

Claudication, Intermittent clinical trials

View clinical trials related to Claudication, Intermittent.

Filter by:

NCT ID: NCT04092972 Recruiting - Clinical trials for Peripheral Arterial Disease

Safety and Efficacy of Atherectomy on VasculaR Functions

SAVioR
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Interventional strategies aim to restore tissue perfusion. However, despite the simple reopening of a narrowed artery they affect endothelial function, perpetuating dysfunctional vascular homeostasis. PTA and atherectomy might alter the endothelial function but the mechanisms are incompletely understood. The primary goal of atherectomy is vessel preparation and improving compliance, which could aid in preserving vessel functions. Aim of this study is to determine safety, efficacy, patency and vessel functions in the femoropopliteal artery following atherectomy and DCB.

NCT ID: NCT03811925 Recruiting - Clinical trials for Peripheral Arterial Disease

SFA TReatment and vAscular Functions

STRAtiFy
Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Endovascular treatment of the superficial femoral artery has a high initial success rate, but restenosis occurs in up to 60% of cases. While restoration of tissue perfusion is achieved, interventional strategies affect endothelial function. Endothelial dysfunction is the pathophysiologic principle involved in the initiation and progression of arteriosclerosis. The aim of this study is to determine the impact of endovascular strategies in the superficial femoral artery on local and systemic endothelial and vascular function.

NCT ID: NCT03594344 Recruiting - Diabetes Mellitus Clinical Trials

Additional Hyperbaric Oxygen After Lower Extremity Amputation

AHOLEA
Start date: July 4, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.

NCT ID: NCT03590769 Completed - Clinical trials for Peripheral Arterial Disease

Arterial Imaging of Inflammation and Resolution After Endovascular Surgery

AIIRES
Start date: June 1, 2017
Phase: Phase 1
Study type: Interventional

This study evaluates the local inflammatory and resolution response of patients undergoing peripheral vascular intervention like an angioplasty of the superficial femoral artery (SFA) or popliteal artery, or stenting of the iliac artery or SFA, through the use of Positron emission tomography-magnetic resonance imaging (PET/MRI). PET/MRI will be performed prior to intervention, one day and one week after intervention.

NCT ID: NCT03266861 Completed - Clinical trials for Peripheral Artery Disease

Lactate Increase in Peripheral Artery Disease

STELLA
Start date: October 3, 2017
Phase:
Study type: Observational

To our knowledge, the measurement of the transcutaneous oxygen pressure during walking is the only continuous method that estimates the importance of ischemia, bilaterally and segment of limb by segment of limb. The determination of the lactates concentration, with micro method from earlobe sampling, is very widely validated in physiology and exercise physiopathology; and it is widely used, by laboratories, for exercise investigation in athletes. We use it in routine to evaluate the presence of functional limitation during tcpO2 tests on a treadmill. The present study hypothesises a significant relationship between lactatemia variation (difference between lactatemia after 3 minutes of recovery from walking and the value at rest) and tcpO2 "decrease from rest of oxygen pressure (DROP) values for patients with peripheral artery disease (PAD).

NCT ID: NCT03203239 Recruiting - Clinical trials for Peripheral Artery Disease

Red Light Treatment in Peripheral Artery Disease

Start date: January 17, 2018
Phase: N/A
Study type: Interventional

Subjects with a known diagnosis of peripheral artery disease as measured by an abnormal ankle brachial index (<.9 or >1.1) will undergo a single 5 min exposure of 670 nm light, 1 cm above the gastrocnemius muscle. Blood flow will be measured by infusion of ultrasound contrast and subsequent acquisition of ultrasound images. 2 blood samples will be collected for measurement of nitric oxide metabolites.

NCT ID: NCT02719665 Completed - Osteoarthritis Clinical Trials

THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease

Start date: March 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to understand the effects of fish oil supplement (containing parts of omega-3 fatty acids) on inflammation. The investigators are aiming to identify which dose of the fish oil supplement is the most effective. The name of the fish oil supplement is "SPM Emulsion."